Country: Awstralja
Lingwa: Ingliż
Sors: Department of Health (Therapeutic Goods Administration)
sotalol hydrochloride, Quantity: 160 mg
Arrotex Pharmaceuticals Pty Ltd
Tablet, uncoated
Excipient Ingredients: magnesium stearate; stearic acid; indigo carmine; maize starch; colloidal anhydrous silica; microcrystalline cellulose; lactose
Oral
60 tablets
(S4) Prescription Only Medicine
APX-SOTALOL is indicated for use in the prevention and treatment of supraventricular and ventricular arrhythmias.
Visual Identification: Light blue, biconvex, capsule shaped tablets, plain on one side and engraved 'S', '160' and a break bar on the other; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius
Registered
2020-05-04
APX-SOTALOL- Consumer Medicine Information Page 1 of 3 APX-SOTALOL _sotalol hydrochloride _ CONSUMER MEDICINE INFORMATION (CMI) WHAT IS IN THIS LEAFLET This leaflet answers some common questions about APX- SOTALOL. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits . Your doctor has weighed the risks of you using APX- SOTALOL against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT USING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT APX-SOTALOL IS USED FOR APX-SOTALOL contains sotalol hydrochloride as the active ingredient which belongs to the family of drugs known as beta- blockers. APX-SOTALOL is used to treat “arrhythmias”, which is a problem when the heart beats too quickly or with the wrong rhythm. APX-SOTALOL slows down and steadies the heart beat, reducing the effort the heart has to put into pumping blood. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY APX- SOTALOL HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed it for another reason. There is no evidence that this medicine is addictive. APX-SOTALOL is only available with a doctor’s prescription. BEFORE USING IT _WHEN YOU MUST NOT USE IT _ _ _ DO NOT USE APX-SOTALOL IF YOU HAVE AN ALLERGY TO: • sotalol hydrochloride • any of the ingredients listed at the end of this leaflet Some of the symptoms of an allergic reaction may include: • shortness of breath, wheezing or difficulty breathing • skin rash, itching or hives • swelling of the face, lips, tongue or any part of the body. DO NOT TAKE APX-SOTALOL IF YOU HAVE ASTHMA. YOU SHOULD NOT TAKE THIS MEDICINE IF YOU HAVE ALLERGIES, OR PROBLEMS WITH YOUR KIDNEYS OR THYROID GLAND, UNLESS YOU HAVE DISCUSSED IT WITH YOUR DOCTOR. YOU SHOULD NOT TAKE THIS MEDICINE IF YOU ARE PREGNANT OR ARE BREAST FEEDING, OR IF YOU INTEND TO BREAST FEED. IF YOU HAVE ANY PROBLEMS WITH YOUR HEA Aqra d-dokument sħiħ
1 AUSTRALIAN PI APX-SOTALOL (SOTALOL HYDROCHLORIDE) TABLETS 1 NAME OF THE MEDICINE Sotalol hydrochloride 2 QUALITATIVE AND QUANTITATIVE COMPOSITION APX-SOTALOL sotalol hydrochloride 80mg tablet contains 80 mg sotalol hydrochloride. APX-SOTALOL sotalol hydrochloride 160mg tablet contains 160 mg sotalol hydrochloride. Excipients with known effect: Contains "Sugars as lactose". For the full list of excipients, SEE SECTION 6.1 LIST OF EXCIPIENTS. 3 PHARMACEUTICAL FORM APX-SOTALOL sotalol hydrochloride 80mg are light blue, biconvex, capsule shaped tablets, plain on one side and engraved 'S', '80' and a break bar on the other side. APX-SOTALOL sotalol hydrochloride 160mg are light blue, biconvex, capsule shaped tablets, plain on one side and engraved 'S', '160' and a break bar on the other side. 4 CLINICAL PARTICULARS 4.1 T HERAPEUTIC INDICATIONS APX-SOTALOL is indicated for use in the prevention and treatment of supraventricular and ventricular arrhythmias. 4.2 D OSE AND METHOD OF ADMINISTRATION APX-SOTALOL is administered orally for the prevention and treatment of arrhythmias. An intravenous formulation is useful for the management of acute arrhythmias. As with other antiarrhythmic agents, APX-SOTALOL should be initiated and doses increased in a facility capable of monitoring and assessing cardiac rhythm. The dosage must be individualized for each patient on the basis of therapeutic response and tolerance. 2 Proarrhythmic events can occur not only at initiation of therapy, but also with each upward dosage adjustment. ORAL APX-SOTALOL should be taken preferably 1-2 hours before meals. Oral dosage of APX-SOTALOL should be adjusted gradually allowing 2-3 days between dosing increments in order to attain steady-state, and to allow monitoring of QT intervals. Graded dose adjustment will help prevent the use of doses which are higher than necessary to control the arrhythmia. The recommended initial oral dosing schedule is 160mg/daily, given in two divided doses at approximately 12 hour intervals. This dose may be increased Aqra d-dokument sħiħ